Literature DB >> 9302017

ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.

V Finck-Barbançon1, J Goranson, L Zhu, T Sawa, J P Wiener-Kronish, S M Fleiszig, C Wu, L Mende-Mueller, D W Frank.   

Abstract

The production of exoenzyme S is correlated with the ability of Pseudomonas aeruginosa to disseminate from epithelial colonization sites and cause a fatal sepsis in burn injury and acute lung infection models. Exoenzyme S is purified from culture supernatants as a non-covalent aggregate of two polypeptides, ExoS and ExoT. ExoS and ExoT are encoded by separate but highly similar genes, exoS and exoT. Clinical isolates that injure lung epithelium in vivo and that are cytotoxic in vitro possess exoT but lack exoS, suggesting that ExoS is not the cytotoxin responsible for the pathology and cell death measured in these assays. We constructed a specific mutation in exoT and showed that this strain, PA103 exoT::Tc, was cytotoxic in vitro and caused epithelial injury in vivo, indicating that another cytotoxin was responsible for the observed pathology. To identify the protein associated with acute cytotoxicity, we compared extracellular protein profiles of PA103, its isogenic non-cytotoxic derivative PA103 exsA::omega and several cytotoxic and non-cytotoxic P. aeruginosa clinical isolates. This analysis indicated that, in addition to expression of ExoT, expression of a 70-kDa protein correlated with the cytotoxic phenotype. Specific antibodies to the 70-kDa protein bound to extracellular proteins from cytotoxic isolates but failed to bind to similar antigen preparations from non-cytotoxic strains or PA103 exsA::omega. To clone the gene encoding this potential cytotoxin we used Tn5Tc mutagenesis and immunoblot screening to isolate an insertional mutant, PA103exoU:: Tn5Tc, which no longer expressed the 70-kDa extracellular protein but maintained expression of ExoT. PA103 exoU::Tn5Tc was non-cytotoxic and failed to injure the epithelium in an acute lung infection model. Complementation of PA103exoU::Tn5Tc with exoU restored cytotoxicity and epithelial injury. ExoU, ExoS and ExoT share similar promoter structures and an identical binding site for the transcriptional activator, ExsA, data consistent with their co-ordinate regulation. In addition, all three proteins are nearly identical in the first six amino acids, suggesting a common amino terminal motif that may be involved in the recognition of the type III secretory apparatus of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302017     DOI: 10.1046/j.1365-2958.1997.4891851.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  244 in total

Review 1.  Bacteriophages in the evolution of pathogen-host interactions.

Authors:  E A Miao; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.

Authors:  D Dacheux; I Attree; B Toussaint
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.

Authors:  Julio C Ramirez; Suzanne M J Fleiszig; Aaron B Sullivan; Connie Tam; Roya Borazjani; David J Evans
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

5.  Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa.

Authors:  N Cole; S Bao; M Willcox; A J Husband
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa.

Authors:  Xiang Xu; Hong Zhang; Yuanlin Song; Susan V Lynch; Clifford A Lowell; Jeanine P Wiener-Kronish; George H Caughey
Journal:  J Leukoc Biol       Date:  2011-11-10       Impact factor: 4.962

7.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Structural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding protein.

Authors:  Robert C Bernhards; Xing Jing; Nancy J Vogelaar; Howard Robinson; Florian D Schubot
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

9.  The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.

Authors:  L Garrity-Ryan; S Shafikhani; P Balachandran; L Nguyen; J Oza; T Jakobsen; J Sargent; X Fang; S Cordwell; M A Matthay; J N Engel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas.

Authors:  Guy Schoehn; Anne Marie Di Guilmi; David Lemaire; Ina Attree; Winfried Weissenhorn; Andréa Dessen
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.